Brief: Fusion Antibodies Signs Collaboration Deal With National Cancer Institute For Use Of Optimal

Fusion Antibodies

28/11/2023 07:41

Nov 28 (Reuters) - Fusion Antibodies PLC  FAB.L :
    * OPTIMAL COLLABORATION AGREEMENT
    * SIGNED A COLLABORATION AGREEMENT WITH NATIONAL CANCER
INSTITUTE
FOR USE OF OPTIMAL

Source text for Eikon:  ID:nRSb8229Ua 
Further company coverage:  FAB.L 

 ((Reuters.Briefs@thomsonreuters.com;))